前收市價 | 574.59 |
開市 | 578.00 |
買盤 | 575.71 x 800 |
賣出價 | 576.05 x 800 |
今日波幅 | 565.23 - 586.46 |
52 週波幅 | 415.60 - 603.82 |
成交量 | |
平均成交量 | 1,456,108 |
市值 | 220.094B |
Beta 值 (5 年,每月) | 0.80 |
市盈率 (最近 12 個月) | 37.30 |
每股盈利 (最近 12 個月) | 15.46 |
業績公佈日 | 2024年4月24日 |
遠期股息及收益率 | 1.56 (0.27%) |
除息日 | 2024年3月14日 |
1 年預測目標價 | 609.83 |
TMO earnings call for the period ending March 31, 2024.
Thermo Fisher's (TMO) first-quarter 2024 revenues register year-over-year growth driven by new product launches.
On Wednesday, Thermo Fisher Scientific Inc. (NYSE: TMO) posted a first-quarter revenue of $10.34 billion, down 3% year over year, beating the consensus of $10.17 billion. Organic revenue was 4% lower, and core organic revenue growth declined by 3%. Revenue from the Life Sciences Solutions Segment declined by 12.5% to $2.29 billion. Analytical Instruments Segment sales were down 2.1% to $1.69 billion. Specialty Diagnostics Segment revenues were almost flat at $1.1 billion, and Laboratory Products